Literature DB >> 28612330

Endothelial cell changes after photorefractive keratectomy with graded usage of mitomycin C.

Hamid Gharaee1, Siamak Zarei-Ghanavati1, Reza Alizadeh2, Mojtaba Abrishami3.   

Abstract

PURPOSE: To compare differences in the endothelial cells before and after photorefractive keratectomy (PRK) for myopia with refractive error graded mitomycin C (MMC) application.
METHODS: In a prospective randomized clinical trial, forty-eight myopic patients referred to Khatam-al-Anbia Eye Hospital, Mashhad, Iran, for PRK. Patients were treated with PRK by a Bausch and Lomb Technolas 217z excimer laser (Bausch and Lomb, Rochester, NY). MMC was applied after PRK 5 s for each diopter of spherical equivalent myopic refractive error corrected. The manifest refraction, visual acuity, MMC treatment length, corneal pachymetry and specular microscopy were evaluated preoperatively and at 1 and 6 months postoperatively.
RESULTS: A total of 48 cases (96 eyes, 68.75% female) were treated, with a mean age of 26.70 ± 4.89 years (range, 18-34 years). Postoperative cell density, cell size and polymegathism did not significantly change. On the other hand, standard deviation (SD) of cell size (P = 0.008), pleomorphism (P = 0.003) and coefficient of variation (CV) (P = 0.016) were significantly increased. None of these parameters was related to the length of MMC application. Corneal thickness decreased significantly after the operation but it increased 6 months postoperatively compared with the first month (P < 0.001).
CONCLUSION: MMC application for PRK in myopia can affect the endothelial cells, but in early follow-ups, it does not affect the cell density or size. Cell size was changed but it was obvious not in mean cell size, but in SD and CV. MMC time below the 30 s was not significant on endothelial cell changes.

Entities:  

Keywords:  Endothelial cell; Mitomycin; Photorefractive keratectomy

Mesh:

Substances:

Year:  2017        PMID: 28612330     DOI: 10.1007/s10792-017-0584-5

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  30 in total

1.  Effectiveness of intra-operative Mitomycin-C in reducing the recurrence of pterygium in Irrua, Nigeria.

Authors:  M E Enock; A E Omoti; O A Dawodu; U C Fuh; I E Eguaoje
Journal:  Niger Postgrad Med J       Date:  2010-03

2.  Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy.

Authors:  Alberto J Morales; David Zadok; Rolando Mora-Retana; Eduardo Martínez-Gama; Nora E Robledo; Arturo S Chayet
Journal:  Am J Ophthalmol       Date:  2006-09       Impact factor: 5.258

3.  Successful treatment of necrotizing scleritis after conjunctival autografting for pterygium with amniotic membrane transplantation.

Authors:  Aylin Karalezli; Cem Kucukerdonmez; Mehmet Borazan; Yonca A Akova
Journal:  Orbit       Date:  2010-04

Review 4.  Mitomycin C: biological effects and use in refractive surgery.

Authors:  Marcony R Santhiago; Marcelo V Netto; Steven E Wilson
Journal:  Cornea       Date:  2012-03       Impact factor: 2.651

Review 5.  Acute scleral thinning after pterygium excision with intraoperative mitomycin C: a case report of scleral dellen after bare sclera technique and review of the literature.

Authors:  Yi-Yu Tsai; Jane-Ming Lin; Jium-Dar Shy
Journal:  Cornea       Date:  2002-03       Impact factor: 2.651

6.  Preoperative subpterygial mitomycin C injection versus limbal conjunctival autograft transplantation for prevention of pterygium recurrence.

Authors:  Sameh S Mandour; Hassan G Farahat; Hala M Mohamed
Journal:  J Ocul Pharmacol Ther       Date:  2011-10-12       Impact factor: 2.671

7.  Surgically induced necrotizing scleritis after pterygium surgery with conjunctival autograft.

Authors:  Vandana Jain; Debraj Shome; Sundaram Natarajan; Rohit Narverkar
Journal:  Cornea       Date:  2008-07       Impact factor: 2.651

8.  Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery.

Authors:  V P Costa; R P Wilson; M R Moster; C M Schmidt; S Gandham
Journal:  Ophthalmic Surg       Date:  1993-06

9.  Fungal scleral keratitis and endophthalmitis following pterygium excision.

Authors:  Vasileios Peponis; Pinchas Rosenberg; Spyridon E Chalkiadakis; Michael Insler; Apostolos Amariotakis
Journal:  Eur J Ophthalmol       Date:  2009 May-Jun       Impact factor: 2.597

10.  Short-time mitomycin-C application during photorefractive keratectomy in patients with low myopia.

Authors:  Ahmad Shojaei; Mohsen Ramezanzadeh; Saeed Soleyman-Jahi; Mina Almasi-Nasrabadi; Parisa Rezazadeh; Medi Eslani
Journal:  J Cataract Refract Surg       Date:  2012-11-23       Impact factor: 3.351

View more
  4 in total

Review 1.  A Critical Overview of the Biological Effects of Mitomycin C Application on the Cornea Following Refractive Surgery.

Authors:  Esther Arranz-Marquez; Andreas Katsanos; Vassilios P Kozobolis; Anastasios G P Konstas; Miguel A Teus
Journal:  Adv Ther       Date:  2019-03-11       Impact factor: 3.845

2.  Effect of Transepithelial Photorefractive Keratectomy without Mitomycin C in the Treatment of Femtosecond Laser In Situ Keratomileusis Corneal Flap Complications.

Authors:  Jing Wang; Weiqian Cao; Liming Tao
Journal:  J Ophthalmol       Date:  2021-01-13       Impact factor: 1.909

3.  Effect of Prophylactic Mitomycin C on Corneal Endothelium Following Transepithelial Photorefractive Keratectomy in Myopic Patients.

Authors:  Mansour M Al-Mohaimeed
Journal:  Clin Ophthalmol       Date:  2022-08-25

4.  Safety and efficacy of combination of suberoylamilide hydroxyamic acid and mitomycin C in reducing pro-fibrotic changes in human corneal epithelial cells.

Authors:  Rohit Shetty; Nimisha Rajiv Kumar; Murali Subramani; Lekshmi Krishna; Ponnalagu Murugeswari; Himanshu Matalia; Pooja Khamar; Zelda V Dadachanji; Rajiv R Mohan; Arkasubhra Ghosh; Debashish Das
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.